Conferences
11–13 June 2025, Nantes, France
Group for the Promotion of Pharmaceutical chemistry in Academia (GP2A)
The GP2A (Group for the Promotion of Pharmaceutical chemistry in Academia), the Paul Ehrlich MedChem Euro-PhD Network, and COST Action OneHealthdrugs are delighted to announce their joint event, the 33rd Annual GP2A Medicinal Chemistry Conference, XIVth Paul Ehrlich MedChem Euro-PhD Network Meeting, and COST Action One Health drugs against parasitic vector borne diseases in Europe and beyond, which will be held at Nantes Université, France, from 11 to 13 June 2025.
The event will take place at the Amphitheatre Virginie Ferré, School of Pharmacy—9 rue Bias 44035 Nantes (GPS 47.2101322,−1.5574098).
Adding to the excitement, the Editor-in-Chief of Drugs and Drug Candidates (ISSN: 2813-2998), Dr. Jean Jacques Vanden Eynde, and Editorial Board Member Dr. Annie Mayence will be attending the conference. They will be present at the DDC booth and warmly welcome all scholars to visit and engage in insightful discussions. This event presents a unique opportunity for participants to interact with leading experts in the field and explore potential collaborations. Do not miss the chance to exchange knowledge and ideas with DDC’s Editors and other delegates during the conference.
For more information, please visit the following link:
https://gp2a.org/index.php/gp2a-2025-paul-ehrlich-medchem-2025-nantes-france-june-11th-to-13th-2025/
